PARLIAMENT QUESTION: HOMI BHABHA CANCER HOSPITALS AND RADIOPHARMACEUTICAL PRODUCTION CENTRES

PARLIAMENT QUESTION: HOMI BHABHA CANCER HOSPITALS AND RADIOPHARMACEUTICAL PRODUCTION CENTRES

 

Sr.

No.

 

Name of the Hospital

 

City, State

 

Date of commissioning

 

Beds

No. of Patient

Registered in 2025

No. of surgeries

performed in 2025

1

Tata Memorial Hospital

Mumbai, Maharashtra

1941

650

35705

43208

 

2

Advanced       Centre        for Treatment,    Research    and

Education        in         Cancer (ACTREC)

Navi Mumbai, Maharashtra

 

2002

 

500

 

8970

 

12588

 

3

Mahamana Pt. Madan Mohan Malaviya Cancer Centre  (MPMMCC)  at

Varanasi

Varanasi, Uttar Pradesh

 

19/02/2019

 

394

 

25047

 

4188

4

Homi       Bhabha       Cancer Hospital

Varanasi, Uttar Pradesh

01/05/2018

189

2684

556

5

Homi       Bhabha       Cancer

Hospital & Research Centre

Visakhapatnam,

Andhra Pradesh

11/05/2023

210

9751

4581

6

Homi       Bhabha       Cancer Hospital & Research Centre

New Chandigarh, Punjab

24/08/2022

300

10107

4807

7

Homi       Bhabha       Cancer Hospital

Sangrur, Punjab

20/01/2015

150

7796

1963

8

Dr.     B.     Borooah    Cancer

Institute (BBCI)

Guwahati, Assam

27/11/2017

312

9810

4273

9

Homi       Bhabha       Cancer

Hospital       and      Research Centre

Muzaffarpur, Bihar

30/04/2025

107

7526

1212

10

Platinum Jubilee Block

Mumbai,

Maharashtra

Expected

31/03/2027

583

—

—

 

11

Integrated Centre for Treatment, Research, and Education   in   Cancer

(ICTREC)

Khopoli, Raighad, Maharashtra

Expected 27/06/2026

 

75

 

—

 

—

12

Homi       Bhabha       Cancer

Hospital

Bhubaneswar,

Odisha

Expected

07/05/2026

200

—

—

 

Tata Memorial Centre (TMC) under the Administrative control of Department of Atomic Energy expanded in seven states by establishing 11 Hospital/Institutions to provide the comprehensive cancer care at Mumbai, Kharghar-New Mumbai, Punjab, Varanasi, Vizag, Muzaffarupur and Guwahati. TMC created the facility at Khopoli by tapping Indian system of medicine for drug discovery and for cheaper and less side effective drugs. Promotion of Indian and Traditional knowledge of Medicine. Cultivation and Conservation of Medicinal plants unique to India and a 200-bed state-of-the-art cancer hospital and research centre is being established at the NISER Campus, Jatni (Khurda district), Odisha. The current status and the utilization are as follows:

for Exploration and Research (AMDER), has prepared Certified Reference Material (FC-CRM) for rare earth element (REE) required for development and validation of analytical methods, calibration of instruments and quality control. It certifies 13 REEs (Ce, Dy, Er, Eu, Gd, La, Nd, Pr, Sc, Sm, Tb, Y and Yb) and 6 major elements (Al, Ca, Fe, Mg, Mn and P) and is useful in exploration, extraction and process control in REE ore mining. The CRM is the 4th such CRM in the world and first in India. BARC is producing high-purity gallium, indium, and germanium which is vital for use in semiconductors and radiation detectors to support its nuclear power programme. Further, requisite quality lutetium for radiopharmaceutical applications is also produced through isotope enrichment route. These CRM and lutetium based radiopharmaceutical development can be used by industries and hospitals respectively across the country including Odisha.

This Information was submitted by The Minister Of State For Prime Minister’s Office Dr. Jitendra Singh in Lok Sabha on 4th February 2026.

Visitor Counter : 209